Key facts
- It has raised $18.9M; the latest was Secondary Transaction - Private in Aug 2025.
- Notable investors include DBJ Capital, Daiwa Corporate Investment, Mitsui Global Investment, NEC Capital Solutions, Relic — 6 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 6 names
- ·Watchlist + deal alerts for On-Chip Biotechnologies
- ·The full record, as it builds
Funding rounds
No funding rounds for On-Chip Biotechnologies are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About On-Chip Biotechnologies
Developer of a cell sorting device designed to provide damage-free and contamination-free cell sorting. The company's device mounts the liquid transfer system on a disposable exchange-type microchannel chip, eliminates the need for a sheath tank and a waste liquid tank, and separates cells by controlling the flow of the microchannel, enabling clients to minimize sorter-induced cellular stress by adopting a cell separation method that controls the flow of the microchannel.
- Sector
- Healthcare
- HQ
- Tokyo, Japan
- Founded
- 2005
- Employees
- 33
- Website
- on-chip.co.jp/
- Ownership
- Privately Held (backing)
On-Chip Biotechnologies doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in On-Chip Biotechnologies shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on On-Chip Biotechnologies in its N-PORT filings yet. We sweep new filings monthly.